Now that '113 is in the clinic, I would expect that all the investment firms are going to have to recognize '113, and re-do their DCF's on Ariad, and raise guidance in future years?
The opportunity with '113 is clearly larger than the other two compounds combined.. Realistically, is this an end 0f 2013, or sometime in 2014 event?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.